在参与ASCO TAPUR研究的多样化人口中,可针对性基因组变化的流行率
Pam K Mangat1, M Kelsey Kirkwood2, Dominique C Hinshaw2
1American Society of Clinical Oncology, Alexandria, VA, USA. TAPURPublications@asco.org.
NPJ precision oncology
|July 3, 2025
概括
针对性代理和分析利用 (TAPUR) 研究发现,特定的基因变异,如PDGRFA和JAK2,在某些族群中更为常见. 这强调了在临床试验中需要多样化的患者群体,以量身定制的癌症治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 临床试验 临床试验
背景情况:
- 针对性剂和分析利用 (TAPUR) 研究 (NCT02693535) 是一项II期篮子试验.
- 它评估了已知药物标的晚期癌症的向疗法.
- 了解不同种群的基因组变化对于有效治疗至关重要.
研究的目的:
- 在多样化的患者队列中分析可向基因变异的流行率.
- 调查这些变化与人口因素的关联.
- 为制定个性化癌症治疗策略提供信息.
主要方法:
- 对3448名注册人的978个基因变异和生物标志物的分析.
- 评估各种人口因素,包括性别,年龄,种族,种族,BMI,吸烟状况,表现状况和癌症类型.
- 使用了TAPUR研究 (临床试验.gov NCT02693535) 的数据.
主要成果:
- 在西班牙裔与非西班牙裔登记者中发现了PDGRFA的更高患病率.
- 在亚裔与白人注册人中观察到JAK2的更高流行率.
- 在可针对性基因组变化的发生方面,已证明人口结构的变化.
结论:
- 招募多样化的患者群体参加临床试验至关重要.
- 基因组标患病率在不同的人口群体之间存在显著差异.
- 治疗策略可能受益于将患者人口统计数据与瘤特征相结合.
更多相关视频
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.9K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.4K
相关概念视频
Genome-wide Association Studies-GWAS
14.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancers Originate from Somatic Mutations in a Single Cell
13.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
13.0K
